Therapeutic potential of ApoE-mimetic peptides in CNS disorders: Current perspective

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Central nervous system (CNS) disorders present a growing global health challenge, necessitating novel therapeutic strategies.
• Developing effective treatments is hindered by the blood-brain barrier (BBB), which restricts drug entry into the brain.
• Apolipoprotein E (ApoE), crucial for brain function, is a potential therapeutic target, but its large size limits BBB penetration.

Purpose of the Study:

• To review the recent advancements in the development and application of apolipoprotein E (ApoE)-mimetic peptides for CNS disorders.
• To explore the therapeutic potential of ApoE-mimetic peptides in overcoming BBB impermeability for neurological conditions.

Main Methods:

• Literature review of studies investigating ApoE-mimetic peptides in CNS disorders.
• Analysis of the biological functions and BBB permeability of engineered ApoE peptides.
• Evaluation of the efficacy of ApoE-mimetic peptides in preclinical models of neurological diseases.

Main Results:

• ApoE-mimetic peptides are designed as smaller, more permeable alternatives to native ApoE.
• These peptides retain key biological functions of ApoE, including roles in synaptic formation and myelination.
• Investigational studies demonstrate the potential of ApoE-mimetic peptides in various CNS disorder contexts.

Conclusions:

• ApoE-mimetic peptides represent a promising strategy to address the challenge of drug delivery across the BBB for CNS disorders.
• Further research into these peptides could lead to novel disease-modifying therapies for neurological conditions.
• The development of ApoE-mimetic peptides offers a viable approach to harness ApoE's therapeutic benefits for brain disorders.